130 related articles for article (PubMed ID: 15487972)
1. Preventing intrathecal administration of vincristine.
Gilbar PJ; Carrington CV
Med J Aust; 2004 Oct; 181(8):464. PubMed ID: 15487972
[No Abstract] [Full Text] [Related]
2. Inadvertent intrathecal administration of vincristine: has anything changed?
Gilbar P
J Oncol Pharm Pract; 2012 Mar; 18(1):155-7. PubMed ID: 21965437
[No Abstract] [Full Text] [Related]
3. Simple method to eliminate the risk of inadvertent intrathecal vincristine administration.
Stefanou A; Dooley M
J Clin Oncol; 2003 May; 21(10):2044; author reply 244. PubMed ID: 12743160
[No Abstract] [Full Text] [Related]
4. Preventing vincristine administration errors.
Jt Comm Perspect; 2005 Sep; 25(9):10-1. PubMed ID: 16515351
[No Abstract] [Full Text] [Related]
5. Prevent inadvertent administration of intrathecal vincristine.
Eisenberg S
ONS Connect; 2009 Jan; 24(1):22. PubMed ID: 19253477
[No Abstract] [Full Text] [Related]
6. Preventing vincristine administration errors: Does evidence support minibag infusions?
Schulmeister L
Clin J Oncol Nurs; 2006 Apr; 10(2):271-3. PubMed ID: 16708708
[TBL] [Abstract][Full Text] [Related]
7. Simple methods of preventing cytotoxic disasters.
Crotty GM
Br J Haematol; 2000 Sep; 110(3):753. PubMed ID: 10997998
[No Abstract] [Full Text] [Related]
8. Not again! Erroneous intrathecal injection results from a problem with protocols.
Seale JR
BMJ; 2001 Mar; 322(7285):548. PubMed ID: 11230084
[No Abstract] [Full Text] [Related]
9. The quest to eliminate intrathecal vincristine errors: a 40-year journey.
Noble DJ; Donaldson LJ
Qual Saf Health Care; 2010 Aug; 19(4):323-6. PubMed ID: 20211962
[TBL] [Abstract][Full Text] [Related]
10. Infallible measures needed to prevent errors in the administration of chemotherapeutic agents.
Anderson RA; Wolff JE; Egeler RM; Coppes MJ
Med Pediatr Oncol; 1999 May; 32(5):401-2. PubMed ID: 10219350
[No Abstract] [Full Text] [Related]
11. Medical errors. Appropriate training should avoid accidental intrathecal injection of vincristine.
Root T;
BMJ; 2001 Jun; 322(7299):1423. PubMed ID: 11417550
[No Abstract] [Full Text] [Related]
12. Preventing vincristine administration errors.
Sentinel Event Alert; 2005 Jul; (34):1-3. PubMed ID: 16021731
[No Abstract] [Full Text] [Related]
13. Intrathecal vincristine: an analysis of reasons for recurrent fatal chemotherapeutic error with recommendations for prevention.
Fernandez CV; Esau R; Hamilton D; Fitzsimmons B; Pritchard S
J Pediatr Hematol Oncol; 1998; 20(6):587-90. PubMed ID: 9856687
[TBL] [Abstract][Full Text] [Related]
14. Inadvertent intrathecal administration of intravenous vincristine.
Seger AC
J Pediatr Hematol Oncol; 2010 Mar; 32(2):167. PubMed ID: 20147847
[No Abstract] [Full Text] [Related]
15. Preventing vincristine sulfate medication errors.
Schulmeister L
Oncol Nurs Forum; 2004 Sep; 31(5):E90-8. PubMed ID: 15378106
[TBL] [Abstract][Full Text] [Related]
16. Not again!
Berwick DM
BMJ; 2001 Feb; 322(7281):247-8. PubMed ID: 11157508
[No Abstract] [Full Text] [Related]
17. Vincristine: right drug, wrong route.
Karch AM
Am J Nurs; 2006 Jan; 106(1):31-2. PubMed ID: 16481774
[No Abstract] [Full Text] [Related]
18. Intrathecal vincristine: fatal myeloencephalopathy despite cerebrospinal fluid perfusion.
Alcaraz A; Rey C; Concha A; Medina A
J Toxicol Clin Toxicol; 2002; 40(5):557-61. PubMed ID: 12215050
[TBL] [Abstract][Full Text] [Related]
19. Accidental intrathecal injection of vincristine.
Root T
J Oncol Pharm Pract; 2005 Mar; 11(1):35. PubMed ID: 16460602
[No Abstract] [Full Text] [Related]
20. Errors involving pediatric patients receiving chemotherapy: a literature review.
Walter AW
Med Pediatr Oncol; 1997 Aug; 29(2):155-6. PubMed ID: 9180921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
